TY - JOUR
PY - 2014//
TI - Patient recall of health care provider counseling for opioid-acetaminophen prescriptions
JO - Pain medicine
A1 - Cameron, Kenzie A.
A1 - McCarthy, Danielle M.
A1 - King, Jennifer P.
A1 - Mullen, Rebecca J.
A1 - Bailey, Stacy Cooper
A1 - Jacobson, Kara L.
A1 - Di Francesco, Lorenzo
A1 - Davis, Terry C.
A1 - Parker, Ruth M.
A1 - Wolf, Mike S.
SP - 1750
EP - 1756
VL - 15
IS - 10
N2 - OBJECTIVE: The aim of this study was to determine the frequency and nature of physician, nurse, and pharmacist verbal counseling at the time of a new prescription for an opioid-acetaminophen containing medication as recalled by patients.
DESIGN: A mixed methods approach with data from cross sectional, structured interviews was used. SETTING: The settings were one academic emergency department in Chicago, IL and one outpatient pharmacy at a public hospital in Atlanta, GA. PATIENTS: One hundred forty-nine patients receiving a new prescription for an opioid-acetaminophen medication were enrolled.
METHODS: Interviews assessed patient recall of counseling they received from their physician, nurse, and pharmacist upon receiving the new prescription. Their responses were unitized and assigned to categories.
RESULTS: One hundred forty-nine patients were enrolled; 61.1% African American and 58.4% female. Seven major categories of responses were noted; frequencies of patient recall for counseling in these categories were reported. Four categories related to the content of the counseling discussion were 1) details of administration (patient recall counseling from: physician/nurse only 44.3%, pharmacist only 5.4%, both providers 12.8%); 2) activities to avoid and side effects (36.2%, 4.7%, 8.7%); 3) medication indication (32.9%, 4%, 4%); and 4) addictive potential (9.3%, 1.3%, 0%). Three categories describe patients' recall of the interaction in broad terms: 5) being referred to print informational material accompanying the prescription (MD/RN only 7.4%, pharmacist only 20.1%, both providers 2.7%); 6) having questions solicited (0%, 11.4%, 0%); 7) having no interaction relating to medication counseling (3.4%, 32.2%, 1.3%).
CONCLUSIONS: Patients infrequently recall counseling from providers on topics that are important to prevent harm from opioid-acetaminophen prescriptions. Future patient-centered clinical research should target identifying optimal strategies to convey these critical messages.
Language: en
LA - en SN - 1526-2375 UR - http://dx.doi.org/10.1111/pme.12499 ID - ref1 ER -